"Promising New Drug Offers Hope for Hard-to-Treat Asbestos-Linked Cancer"

Scientists at Queen Mary University of London have developed a new drug, ADI-PEG20, which has shown promising results in treating mesothelioma, a hard-to-treat and aggressive form of cancer. The drug, which works by cutting off the tumor's food supply, has quadrupled three-year survival rates and increased average survival by 1.6 months. This breakthrough marks the first successful combination of chemotherapy with a drug that targets cancer's metabolism for this disease in 20 years, offering hope to patients and the medical community.